Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.680
-0.020 (-2.88%)
At close: Feb 21, 2025, 4:00 PM
0.690
+0.010 (1.46%)
After-hours: Feb 21, 2025, 7:58 PM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $198.48 million as of February 21, 2025. Its market cap has increased by 48.23% in one year.
Market Cap
198.48M
Enterprise Value
166.57M
1-Year Change
48.23%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $198.48M, an increase of 56.53%. That is a compound annual growth rate of 4.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 198.10M | -15.52% |
| Dec 31, 2024 | 234.50M | 58.98% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |